Pharmaceutical companies who want to launch an injection pen or an autoinjector are faced with several challenges. Once the active ingredient has been developed and is undergoing trials, the appropriate injection device has to be identified and market approval obtained. On the way to the finished product, pharmaceutical companies not only have to deal with approval authorities but also with various companies: the device manufacturer, the manufacturer of the filling machine as well as one or more manufacturers of assembly and packaging machines.
This involves a great deal of coordination. Harro Höfliger recognized this challenge at an early stage and has continuously expanded its service and consulting offerings. Together with Ypsomed, Harro Höfliger has established a joint production network, in which device and machine manufacturers work hand in hand with pharmaceutical companies.
“One-time docking”: a global first
The complex pre-assembly of the injection devices takes place directly at Ypsomed. The device manufacturer can guarantee its consistently high quality through high-precision assembly and control processes. The pre-assembled devices are assembled with the syringes or cartridges and packaged at the pharmaceutical company or contract manufacturer. Filling of the active ingredient takes place at the pharmaceutical company or contract manufacturer on a special filling machine.
This is where a specialist for the filling of liquids such as Bausch+Ströbel comes into play. Due to the long-standing cooperation within the Excellence United network, the production lines of Bausch+Ströbel can be easily integrated into the lines of Harro Höfliger. The benefits of this close cooperation are also reflected in the project flow, thanks to reduced interfaces and collective expertise. Harro Höfliger offers tailor-made machine platforms from laboratory to full-scale production for both the final assembly and the subsequent packaging tasks of the devices.